Retatrutide 50mg — Vial Spec, Reconstitution Math & COA

Overview of the 50mg Retatrutide Research Specification

A 50mg vial of retatrutide represents a high-capacity, laboratory-grade lyophilized peptide formulation engineered for extensive preclinical study protocols. Retatrutide is a synthetic peptide single sequence possessing triple agonist activity at the glucagon-like peptide-1 (GLP-1), glucose-dependent insulinotropic polypeptide (GIP), and glucagon (GCG) receptors. Supplying retatrutide in a 50mg format allows research laboratories conducting high-volume assays or long-term rodent cohort investigations to minimize lot-to-lot variance by utilizing a single uniform batch across multiple experimental replicates.

In experimental settings, a retatrutide 50mg vial is typically utilized by academic, institutional, and private research teams running continuous microplate binding assays, cellular signaling kinetics, or multi-week preclinical metabolic models. Note on availability: PX1 Research supplies high-purity research peptides engineered to rigorous standards. If the exact 50mg single-vial unit is currently out of stock or reserved for custom institutional synthesis via our wholesale lab account portal, researchers can inspect standard available fill sizes across our comprehensive all peptides catalog or directly access our core triple-agonist offering via the GLP3-R product page.

Triple-Agonist Mechanism of Action in Preclinical Models

Preclinical studies suggest that retatrutide functions as a potent peptide chimera engineered to simultaneously activate three distinct metabolic G-protein coupled receptors (GPCRs). In vitro signaling assays demonstrate that its molecular structure confers balanced potency across the human GLP-1, GIP, and glucagon receptors, driving intracellular cyclic AMP (cAMP) accumulation in transfected cell lines. This tri-agonist profile enables researchers to investigate synergistic downstream pathways that single or dual incretin mimetics cannot fully activate.

When evaluated against comparative metabolic research peptides, retatrutide offers a broader receptor activation profile. For instance, dual GLP-1/GIP receptor agonists such as tirzepatide activate two key incretin pathways, whereas selective GLP-1 receptor agonists like semaglutide focus exclusively on GLP-1 signaling. Additionally, researchers comparing multi-pathway weight and glycemic control models often evaluate retatrutide alongside non-incretin amylin analogs such as cagrilintide to map additive metabolic effects in animal models. Retatrutide 50mg provides the material scale necessary for complex multi-arm comparative assays.

Reconstitution Math and Volumetric Concentration Calculations

Reconstituting a retatrutide 50mg vial requires precise calculation of diluent volume to achieve the desired working concentration for micro-pipetting or automated fluid delivery systems. Because 50mg is a substantial mass of peptide, researchers must select diluent volumes that balance target concentration with solubility limits. Utilizing standard sterile diluents—such as Bacteriostatic Water (0.9% Benzyl Alcohol) or Sterile Normal Saline (0.9% NaCl)—yields predictable mathematical ratios.

Below are standard volumetric outcomes when reconstituting a 50mg vial of retatrutide:

1. Reconstitution with 1.0 mL Diluent: Yields a final working concentration of 50.0 mg/mL (50 µg per µL). This high-density concentration is ideal for low-volume aliquot freezing or micro-dosing in sub-microliter automated dispensers.

2. Reconstitution with 2.0 mL Diluent: Yields a final working concentration of 25.0 mg/mL (25 µg per µL). This intermediate density facilitates standard laboratory handling while minimizing required storage volume.

3. Reconstitution with 3.0 mL Diluent: Yields a final working concentration of 16.67 mg/mL (16.67 µg per µL). This concentration reduces volumetric margin-of-error during pipette transfers for larger tissue culture wells or higher-mass animal dosing protocols.

To quickly verify custom concentration-to-volume ratios or calculate micro-liter draw volumes for specific assay targets, investigators should utilize the interactive PX1 reconstitution calculator.

Aliquot Planning and Long-Term Laboratory Storage Protocols

Lyophilized retatrutide 50mg standard vials maintain exceptional structural integrity when stored sealed under desiccated conditions at -20°C to -80°C. Upon receiving a lot-verified vial from PX1 Research, the dry powder cake should remain undisturbed in freeze storage until the exact day of trial initiation. Avoid subjecting dry or reconstituted peptides to repeated ambient temperature fluctuations.

Once reconstituted, high-mass vials must be managed carefully to prevent activity loss from repeated freeze-thaw cycles. In vitro data indicate that repeated thermal cycling accelerates peptide bond cleavage and aggregation. Researchers should aliquot the newly reconstituted retatrutide solution into single-use low-binding polypropylene micro-centrifuge tubes (e.g., 50 µL to 200 µL per tube). Reconstituted aliquots dissolved in bacteriostatic water retain stability for up to 28 days when refrigerated at 2°C to 8°C, or up to 6 months when flash-frozen and maintained continuously at -80°C.

Analytical Verification: HPLC, Mass Spectrometry, and COA Standards

Quantifying purity and confirming molecular identity are critical prerequisites before introducing any compound into a controlled research model. PX1 Research subjects every synthesis lot of retatrutide to rigorous analytical testing within ISO 17025 accredited, independent third-party laboratories. Every fill size, including high-capacity 50mg batches, is fully certified prior to distribution.

The Lot-Matched Certificate of Analysis (COA) confirms three essential parameters:

1. High-Performance Liquid Chromatography (HPLC): Verifies chemical purity, ensuring target peptide purity meets or exceeds 99.0% with minimal baseline chromatographic impurities.

2. Mass Spectrometry (MS): Confirms exact molecular weight and amino acid sequence identity against theoretical retatrutide molecular mass metrics.

3. Bacterial Endotoxin Testing: Assayed via Limulus Amebocyte Lysate (LAL) testing to confirm endotoxin levels remain below strictly defined thresholds (<0.05 EU/mg), ensuring cell-culture viability and non-pyrogenic properties in animal models.

Researchers can inspect authentic lot documentation directly via our centralized COA verification page to confirm batch parameters before initiating assays.

Vial Size Selection: Evaluating 50mg vs. Lower Fill Capacities

Selecting the appropriate vial mass depends primarily on assay throughput, project duration, and aliquot handling capacity. While a retatrutide 50mg vial is cost-effective and structurally advantageous for large-scale institutional projects, smaller laboratory trials may benefit from reduced mass configurations (such as 5mg or 10mg vials).

High-mass 50mg vials are ideal for continuous high-throughput cell screening platforms where hundreds of assay wells are dosed concurrently from a single master stock solution. Conversely, if an experimental protocol requires intermittent dosing over several months with extended gaps between assays, smaller fill sizes prevent unused reconstituted solution from remaining in liquid storage past its optimal stability window. Principal investigators should balance total protocol mass requirements against storage limitations when planning inventory through the PX1 research library.

Handling Instructions and Reconstitution Best Practices

Proper physical handling during the reconstitution step ensures maximum peptide recovery and maintains structural bioactivity. Retatrutide, like all long-chain synthetic peptides, possesses delicate tertiary conformations that are sensitive to mechanical shear stress.

When introducing diluent to a 50mg lyophilized cake, adhere to the following laboratory protocol: Allow the sealed vial to reach room temperature to prevent condensation inside the stopper. Using a sterile syringe, draw the calculated volume of bacteriostatic water and slowly inject it down the inside glass wall of the vial—never directly onto the powder cake. Allow the lyophilized cake to swell and dissolve passively over 5 to 10 minutes. Gently swirl the vial with a smooth circular wrist motion. Do not vortex or violently shake the vial, as severe agitation causes foaming and structural denaturation.

PX1 Research Quality Standards & Logistics

PX1 Research operates strictly as a premier USA-based supplier of high-purity research compounds for scientific investigation. All peptides are manufactured under strict Good Manufacturing Practice (GMP) compliant guidelines, ensuring lot-to-lot consistency, precise mass filling, and sterile processing.

To support rigorous research timelines, orders are fulfilled directly from our modern climate-controlled distribution facilities located in California and Arizona. PX1 offers same-day shipping for orders placed Monday through Friday prior to cutoff times, guaranteeing that temperature-sensitive compounds arrive promptly with uncompromised integrity. Laboratory purchasing agents seeking bulk allocations or institutional invoicing can explore specialized procurement options on our wholesale accounts portal.